Search

norvatis

Novartis has so far prevailed over rival drug maker Incyte, which also made an offer for MorphoSys.

Consumer & Healthcare

Novartis in the lead to acquire cancer drug developer MorphoSys: sources

DRUG maker Novartis is in advanced talks to acquire MorphoSys, a developer of cancer treatments that has a market value of 1.6 billion euros (S$2.3 billion), two people familiar with the matter said o...

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News

View More